Can blood tranfusion transmit cancer? a literature review

Transfusion Medicine Reviews

Volumn 24, Issue 3, 2010, Pages 235-243

  Yang, Hung ^a,b   Lee, June ^a,b   Seed, Clive R ^a,b   Keller, Anthony J ^a,b  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NEOPLASM; ORGAN TRANSPLANTATION; REVIEW; SKIN CANCER; NEOPLASMS; PRECANCER;

BLOOD DONORS; BLOOD TRANSFUSION; HUMANS; NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 77955166690     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2010.03.005     Document Type: Review

References (49)

1. Zimrin A.B., Hess J.R. Blood donors and the challenges in supplying blood products and factor concentrates. Surgery 2007, 142:S15-S19.
2. Eder A., Goldman M., Rossmann S., et al. Selection criteria to protect the blood donor in North America and Europe: Past (dogma), present (evidence), and future (hemovigilance). Transfus Med Rev 2009, 23:205-220.
3. Australian Red Cross National Blood Transfusion Committee Guidelines for the Selection of Blood Donors: Australian Red Cross 1994.
4. Screening blood donors: Science, reason and the donor history questionnaire 2007, AABB press, Bethesda. A. Eder, C. Bianco (Eds.).
5. Edgren G., Hjalgrim H., Reilly M., et al. Risk of cancer after blood transfusion from donors with subclinical cancer: A retrospective cohort study. Lancet 2007, 369:1724-1730.
6. Hjalgrim H., Edgren G., Rostgaard K., et al. Cancer incidence in blood transfusion recipients. J Natl Cancer Inst 2007, 99:1864-1874.
7. Dzik W.H., Okayama A. Can blood transfusion transmit disease-producing genes?. Transfusion 1999, 39:795-800.
8. Memon A., Doll R. A search for unknown blood-borne oncogenic viruses. Int J Cancer 1994, 58:366-368.
9. Penn I. Transmission of cancer from organ donors. Ann Transplant 1997, 2:7-12.
10. Niederwieser D., Gentilini C., Hegenbart U., et al. Transmission of donor illness by stem cell transplantation: Should screening be different in older donors?. Bone Marrow Transplant 2004, 34:657-665.
11. Gartner V.H., Seidl C., Luckenback C., et al. Genetic analysis of a sarcoma accidentally transplanted from a patient to a surgeon. N Engl J Med 1996, 335:1494-1496.
12. Catlin E.A., Roberts J.D., Erana R., et al. Transplacental transmission of natural-killer-cell lymphoma. N Engl J Med 1999, 341:85-91.
13. Racila E., Euhus D., Weiss A.J., et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A 1998, 95:4589-4594.
14. Lee T.H., Paglieroni T., Ohto H., et al. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: Frequent long-term microchimerism in severe trauma patients. Blood 1999, 93:3127-3139.
15. Vietor H.E., Hallensleben E., van Bree S.P., et al. Survival of donor cells 25 years after intrauterine transfusion. Blood 2000, 95:2709-2714.
16. Vamvakas E.C., Blajchman M.A. Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction. Blood 2001, 97:1180-1195.
17. Stoffel J.T., Topjian L., Libertino J.A. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int 2005, 96:313-315.
18. Davis M., Sofer M., Gomez-Marin O., et al. The use of cell salvage during radical retropubic prostatectomy: Does it influence cancer recurrence?. BJU Int 2003, 91:474-476.
19. Waters J.H. Indications and contraindications of cell salvage. Transfusion 2004, 44:40S-44S.
20. Thiersch J.B. Attempted transmission of human leukemia from man to man by the sternal marrow route. Cancer Res 1946, 6:695-698.
21. Baergen R.N., Johnson D., Moore T., et al. Maternal melanoma metastatic to the placenta: A case report and review of the literature. Arch Pathol Lab Med 1997, 121:508-511.
22. Osada S., Horibe K., Oiwa K., et al. A case of infantile acute monocytic leukemia caused by vertical transmission of the mother's leukemic cells. Cancer 1990, 65:1146-1149.
23. Resnik R. Cancer during pregnancy. N Engl J Med 1999, 341:120-121.
24. Birkeland S.A., Storm H.H. Risk for tumor and other disease transmission by transplantation: A population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation 2002, 74:1409-1413.
25. Feng S., Buell J.F., Chari R.S., et al. Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium. Am J Transplant 2003, 3:1481-1487.
26. Buell J.F., Alloway R.R., Steve Woodle E. How can donors with a previous malignancy be evaluated?. J Hepatol 2006, 45:503-507.
27. Kauffman H.M., McBride M.A., Delmonico F.L. First report of the United Network for Organ Sharing Transplant Tumor Registry: Donors with a history of cancer. Transplantation 2000, 70:1747-1751.
28. Kauffman H.M., McBride M.A., Cherikh W.S., et al. Transplant tumor registry: Donors with central nervous system tumors. Transplantation 2002, 73:579-582.
29. Smith J.L., Heerema N.A., Provisor A.J. Leukaemic transformation of engrafted bone marrow cells. Br J Haematol 1985, 60:415-422.
30. Gandhi M.J., Strong D.M. Donor derived malignancy following transplantation: A review. Cell Tissue Bank 2007, 8:267-286.
31. Niederwieser D.W., Appelbaum F.R., Gastl G., et al. Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med 1990, 322:1794-1796.
32. Berg K.D., Brinster N.K., Huhn K.M., et al. Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med 2001, 345:1458-1463.
33. Baron F., Dresse M.F., Beguin Y. Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation. N Engl J Med 2003, 349:913-914.
34. Glasser L., Meloni-Ehrig A., Greaves W., et al. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: Report of a case with comments on donor evaluation. Transfusion 2009, 49:555-562.
35. Sala-Torra O., Hanna C., Loken M.R., et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006, 12:511-517.
36. Mielcarek M., Bryant E., Loken M., et al. Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation. Blood 2006, 107:1732-1733.
37. Bhagat R., Rizzieri D.A., Vredenburgh J.J., et al. Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?. Chest 2004, 126:642-644.
38. Thiersch J. Attempted transmission of human leukaemia in man. J Lab Clin Med 1945, 30:866-874.
39. Bierman H.R., Byron R.L., Lanman J.T., et al. Disappearance of leukemic cells in nonleukemic recipients during transfusions and cross-circulation studies. Am J Med 1950, 8:522-523.
40. Schiffer C.A., Aisner J., Dutcher J.P., et al. Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia. Am J Hematol 1983, 15:65-74.
41. Freireich E.J., Levin R.H., Whang J., et al. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann N Y Acad Sci 1964, 113:1081-1089.
42. Greenwald P., Woodard E., Nasca P.C., et al. Morbidity and mortality among recipients of blood from preleukemic and prelymphomatous donors. Cancer 1976, 38:324-328.
43. Cerhan J.R., Wallace R.B., Folsom A.R., et al. Transfusion history and cancer risk in older women. Ann Intern Med 1993, 119:8-15.
44. Chow E.J., Holly E.A. Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: A population-based study. Am J Epidemiol 2002, 155:725-731.
45. Edgren G., Hjalgrim H., Tran T.N., et al. A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang 2006, 91:316-323.
46. Goldman M., Fournier E., Cameron-Choi K., et al. Effect of changing the age criteria for blood donors. Vox Sang 2007, 92:368-372.
47. Stainsby D., Butler M. Recommendations for removal of the upper age limit for regular whole blood and component donors 2008.
48. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries Cancer in Australia: An overview, 2008 2008, [Canberra].
49. Coleman M.P., Quaresma M., Berrino F., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9:730-756.